Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Plan to axe 91,000 civil servants ‘only possible with cuts to services’

Review casts doubt on Boris Johnson’s claim that frontline services would not be harmed

The Guardian - UK

LEXX: Put Your Drinks Up! Four Deals Signed in June

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT

Benzinga

Nature's secret drug stockpile

Some scientists are looking for new drugs in nature rather than synthesizing them in the lab. Here's why

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

In fight against monkeypox, government isn’t learning from past experience

The Biden administration’s response has made key mistakes in handling the emerging threat. We hope this situation serves as a wake-up call to rethink and re-tool emergency response policies and practices.

Chicago Sun-Times

FDA considering "dose-sparing" approach to increase availability of Jynneos vaccine

Health care providers could use one vial of the vaccine to administer up to five doses without an impact on safety or efficacy.

Axios

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5

CNBC International Airlines Prepare For Mayhem Of Summer Travel Season: Report

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The next public health emergency

Facing a groundswell of criticism for its sluggish response to monkeypox, the Biden administration declared a public health emergency on Thursday, potentially unlocking millions of dollars toward increasing vaccine availability in the U.S.

Axios

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline B

Benzinga

NYC and San Francisco Prioritize 'First Doses First' for Monkeypox Vaccine. Why Won't the CDC Do the Same?

The CDC and FDA, when confronted with scarce vaccine supply, refuse to learn from their COVID-19 mistakes.

Reason

Administration declares monkeypox a public health emergency - Roll Call

The administration declares monkeypox a public health emergency and says it will make it easier to get vaccines to patients.

Roll Call

Monkeypox Is Giving Public Health Agencies a Chance To Prove They've Learned Nothing From COVID

Plus: Schools surveilling students online, Tim Wu leaving the White House, and more...

Reason

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

The US government’s call for deep nicotine reduction in cigarettes could save millions of lives – an expert who studies tobacco addiction explains

The cigarette is the only legal consumer product that – when used as intended – causes the premature death of half of long-term users.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

Alternate monkeypox treatment caught in regulatory delays

Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

The Independent UK

How common is Paxlovid rebound as Biden tests positive again for Covid?

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.

StockNews.com

5 Value Stocks to Buy Ahead of the Fall Season

The stock market has witnessed a rough ride amid macroeconomic headwinds this year. Despite the GDP decline for two consecutive quarters, economists believe the economy is far from recession. Here are five fundamentally solid value stocks AstroNova (ALOT), Bristol-Myers Squibb (BMY), Bluegreen Vacations (BVH), GSK (GSK), and Honda Motor (HMC),…

Daily Mirror

Woman shames her 'lazy dog' who would rather starve than work for his food

A woman has playfully shamed her dog who would rather skip dinner time than work for his meal - she is now giving away his dog puzzle bowl in hope 'somebody else's dog is smarter than hers'

Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Tribune News Service

Lisa Jarvis: At last, a simple strategy for COVID booster shots

The Food and Drug Administration reportedly has a new strategy for rolling out new booster shots that should bring needed clarity to COVID vaccination in the U.S. Going forward, most Americans will get the same advice about when to get their next shots.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

1 … 173 174 175 176

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations